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Regional Strength in CAM
Edwin L. Cooper
Laboratory of Comparative Neuroimmunology, Department of Neurobiology, David Geffen School of Medicine
at UCLA, University of California, Los Angeles, Los Angeles, California 90095-1763, USA
Several years ago, I spent a sabbatical at University of
Modena, Italy, living nearby in the famous university town
of Bologna. While there, firm roots were established to search
for anticancer molecules and new wave antibiotics (1,2). Far
from my radar screen was another adventure, now unfolding in
Bologna and even for eCAM. Little did I realize that another
visit was simmering and taking shape-long before the birth of
eCAM and the appointment of a strong group of editorial board
members focused around that region of Italy, all professors
and or practitioners in nearby universities: Andrea Cossarizza,
Modena, Claudio Franceschi, Carlo Ventura, Paulo Roberti di
Sarsina, Carla Maria Giovanardi, Bologna, Paulo Bellavite,
Verona, Francesco Marotta, Emilio Minelli, Milan. All are
contributing forcefully to uncovering the basic science and
clinical practice of CAM.
In a sense the seeds for this new plant were nurtured even
earlier when Claudio Franceschi and I first met as immunolo-
gists on leave at the Karolinska Institute, Stockholm, I on my
first sabbatical as a Guggenheim Fellow from UCLA and
Claudio, a younger post doc. Both of us are immunologists.
I worked in the laboratory of Goran and Erna Moller and
Claudio with George and Eva Klein. This was in 1970–71 and
we remained in sporadic contact by my requesting some
of Claudio’s previously published histopathology of spleens
from an exotic animal for my first book, Comparative
Immunology published by Prentice Hall, in 1976 one of several
books in the Immunobiology Series. We met on other occa-
sions mostly through strong mutual interests in the blooming
subject of neuoroendocrine immunology and there luck struck
again where at one symposium, I became immediate friends
with Andrea Cossarizza MD then a PhD student working with
Claudio. Move now from 1990 to 1993 and we witness my
decision to come to University of Modena for my fourth
sabbatical in Claudio’s lab.
Originally wanting to work on immunorecognition in snails
(sharing some work also with another collaborator, Enzo
Ottaviani), as luck would have it I decided almost impulsively
to work on the earthworm with Andrea. Why? Snails were
in hibernation and could not be collected during the fall of
1993. Besides, I had just finished supervising another PhD
student Michael Suzuki at UCLA on the natural cytotoxicity
of earthworm coelomocytes, so all I needed was to convince
(and this was not at all difficult) Andrea to do some ‘‘quick and
dirty experiments’’ and confirm Suzuki’s thesis, co-culturing
earthworm leukocytes with K562, a common tumor cell line
useful for assaying natural cytotoxicity. I wanted especially to
search for the evolutionary precursors of NK cells.
This turned out to be an outstanding adventure, demonstrat-
ing for the first time the distinct separation of phagocytosis
from NK cell killing of foreign tissue antigens. Our work
supported Burnet’s view of immunologic surveillance and
brought back into focus once again since Metchnikoff, the
crucial position of invertebrates and animal models in under-
standing the basic science underlying immune responses, i.e.
the prominent role of innate immunity as essential for survival
of species(3). During that periodinItaly I also spentsome time
with Prof Nicolo Parrinello, University of Palermo working on
the neuroendocrine consequences of stress induced by crowd-
ing on the immune system of fish. It was also of special interest
to look at the antimicrobial peptides of tunicates (actually
some of these are useful as anticancer therapeutics (4).
In the meantime eCAM was born and I turned internation-
ally for experts to serve as Editorial Board members and once
again found myself seriously considering this region of Italy
(5–8). Claudio Franceschi brings to the board his expertise
in senescence, having coined the word centenarians; at the
moment he is exploring the possible role of curcumin in
apoptosis (9). Clearly aging populations could be real targets
for CAM approaches. Andrea Cossarizza and I are once again
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apoptotic activity on leukemic cells and peripheral blood
lymphocytes (10,11). Stem cells reach a high level of
relevance to CAM (12) through the work of Carlo Ventura
(13) in which he proposes cell models with receptors that may
be vulnerable to outside influences. This captures the basic
science approaches to CAM with the ultimate promise of
evidence based, not all clinical but highly relevant.
More recently the importance of acupuncture is evident in
the influence of Carlo Maria Giovarnardi. He is in charge of
the Fondazione Mateo Ricci, an institution dedicated to the
diffusion of acupuncture and traditional Chinese medicine.
Moving somewhat eastward toward Venice, Paulo Bellavite is
exploring all aspects of basic science in relation to homeo-
pathy (14). And then there are the efforts of Emilio Minelli
and Francesco Marotta in Milan. Turning to more clinical
aspects, we are ever mindful of the importance of networking
throughout Italy and internationally by the efforts of Paulo
Roberti di Sarsina that are particularly important here (15).
Let me state at the outset that by briefly focusing on this
region, there is neither particular bias toward CAM in Italy nor
any other country. UCLA where I am based has a Collabora-
tive Centers of Integrative Medicine (CCIM) and there are
certain other similar consortia. There is a large focus in parts
of Asia where our travels have been rather extensive, thanks to
generous invitations. It is only fortuitous that I have been able
to combine my own research interests somewhat independ-
ent of CAM coupled with this current sabbatical (Senior
Visiting Scientist, Institute for Advanced Studies, University
of Bologna;hosted by Claudio Francheschi) with efforts
to stimulate and integrate more CAM activities. It is this spirit
of inquiry, my own, some of which overlap with CAM that
makes this position of Editor in Chief so very rewarding!
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